Ingevity Corporation

NGVT

US45688C1071

Diversified Chemicals

Market Closed - Nyse Other stock markets 01:30:02 29/06/2024 am IST			5-day change	1st Jan Change
43.71 ^USD	-1.60%		-0.43%	-7.43%

07/05	Loop Capital Adjusts Price Target on Ingevity to $56 From $49, Maintains Hold Rating	MT
02/05	Transcript : Ingevity Corporation, Q1 2024 Earnings Call, May 02, 2024

Ingevity Corporation Provides Earnings Guidance for the Year 2021

October 28, 2021 at 01:45 am IST

Ingevity Corporation provided earnings guidance for the year 2021. For the year, the company expects sales between $1.320 billion and $1.360 billion.

Latest news about Ingevity Corporation

Loop Capital Adjusts Price Target on Ingevity to $56 From $49, Maintains Hold Rating	07/05	MT
Transcript : Ingevity Corporation, Q1 2024 Earnings Call, May 02, 2024	02/05
Oppenheimer Adjusts Ingevity Price Target to $58 From $50, Maintains Outperform Rating	02/05	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q1 Revenue $340.1M, vs. Street Est of $319.2M	02/05	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q1 EPS $0.52, vs. Street Est of $0.25	02/05	MT
Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	02/05	CI
Ingevity Corporation Reiterates Earnings Guidance for the Full Year 2024	02/05	CI
Ingevity Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Ingevity Shares Rise After Jefferies Upgrades Stock to Buy From Hold, Raises Price Target	23/04	MT
Jefferies Upgrades Ingevity to Buy From Hold, Raises Price Target to $62 From $52	22/04	MT
Ingevity Corporation Announces Resignation of William J. Slocum from Board	15/03	CI
Transcript : Ingevity Corporation, Q4 2023 Earnings Call, Feb 22, 2024	22/02
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q4 EPS $0.21	22/02	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q4 Revenue $371.7M, vs. Street Est of $332.6M	22/02	MT
Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	22/02	CI
Ingevity Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
Ingevity Corporation Provides Earnings Guidance for the Year 2024	22/02	CI
Ingevity Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02	CI
Activist investor Ubben shutting down Inclusive Capital -WSJ	30/11	RE
Ingevity Extends TRiiSO Collaboration to Expand Capa Distribution Through North America	28/11	MT
Ingevity Corporation Extends Partnership with TRiiSO, LLC, Expands Capa®? Distribution Footprint for Customers in the United States and Canada	28/11	CI
Transcript : Ingevity Corporation, Q3 2023 Earnings Call, Nov 02, 2023	02/11
Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q3 EPS $1.21, vs. Street Est of $1.23	02/11	MT
Earnings Flash (NGVT) INGEVITY CORPORATION Posts Q3 Revenue $446M, vs. Street Est of $464.7M	02/11	MT
Tranche Update on Ingevity Corporation's Equity Buyback Plan announced on August 2, 2022.	02/11	CI

Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.

Sector

Diversified Chemicals

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Ingevity Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

43.71 USD

Average target price

57.6 USD

Spread / Average Target

+31.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
INGEVITY CORPORATION	-7.43%	158.8Cr
SHIN-ETSU CHEMICAL CO., LTD.	+5.43%	7.71TCr
BASF SE	-7.37%	4.32TCr
DUPONT DE NEMOURS, INC.	+4.63%	3.37TCr
PIDILITE INDUSTRIES LIMITED	+16.35%	1.93TCr
EASTMAN CHEMICAL COMPANY	+9.07%	1.15TCr
BRENNTAG SE	-24.35%	974.02Cr
SYENSQO SA/NV	-11.34%	942.18Cr
ASAHI KASEI CORPORATION	-0.82%	888Cr
SRF LIMITED	-1.92%	864.95Cr

Diversified Chemicals